Amy W. Schulman

Executive

Director

Elevance Health, Inc.Alnylam Pharmaceuticals, Inc.Alnylam Pharmaceuticals, Inc.SQZ Biotechnologies Co Fractyl Health, Inc.

Insider activity · 24 months1 buy1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 1 buy · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 1 saleApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (2 ops.)

€27k

▼ Sales (1 ops.)

€6,476

Latest filing published 22 May 2026 for ALNYLAM PHARMACEUTICALS, INC.. Read the official filing

Filing timeline

BuySale

Amy W. Schulman

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Amy W. Schulman: trading record in brief

Amy W. Schulman is a declared insider at 4 companies (senior executive); the most frequent names are Alnylam Pharmaceuticals, Inc., Elevance Health, Inc. and SQZ Biotechnologies Co. The record holds 13 filings, for trades running from 13 December 2021 to 20 May 2026.

Both buying and selling appear: 2 purchases worth €27k, against 1 sale worth €6,476. Taken together, the purchases exceed the sales by €20k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 4 share grants and 6 option exercises. 2026 to date brings no purchases and 1 sale.

The newest entry dates from 22 May 2026: a share grant, in Alnylam Pharmaceuticals, Inc. The clock since the last published purchase (17 March 2025) now reads 580 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.